DD202691A5 - Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols - Google Patents

Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols Download PDF

Info

Publication number
DD202691A5
DD202691A5 DD81242604A DD24260481A DD202691A5 DD 202691 A5 DD202691 A5 DD 202691A5 DD 81242604 A DD81242604 A DD 81242604A DD 24260481 A DD24260481 A DD 24260481A DD 202691 A5 DD202691 A5 DD 202691A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
amino
compounds
salt
acid
Prior art date
Application number
DD81242604A
Other languages
German (de)
English (en)
Inventor
Franz Ostermayer
Markus Zimmermann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD202691A5 publication Critical patent/DD202691A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD81242604A 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols DD202691A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH611880 1980-08-13

Publications (1)

Publication Number Publication Date
DD202691A5 true DD202691A5 (de) 1983-09-28

Family

ID=4304561

Family Applications (3)

Application Number Title Priority Date Filing Date
DD81242604A DD202691A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81232528A DD202286A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81242603A DD202532A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Family Applications After (2)

Application Number Title Priority Date Filing Date
DD81232528A DD202286A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
DD81242603A DD202532A5 (de) 1980-08-13 1981-08-11 Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Country Status (17)

Country Link
EP (1) EP0045964A1 (fr)
JP (1) JPS5759842A (fr)
KR (1) KR840002266B1 (fr)
AR (6) AR231273A1 (fr)
AU (1) AU543647B2 (fr)
CA (1) CA1192221A (fr)
DD (3) DD202691A5 (fr)
DK (1) DK358381A (fr)
ES (8) ES8301462A1 (fr)
FI (1) FI812465L (fr)
GR (1) GR74992B (fr)
HU (1) HU186342B (fr)
IL (1) IL63539A (fr)
NO (1) NO812736L (fr)
NZ (1) NZ198020A (fr)
PT (1) PT73511B (fr)
ZA (1) ZA815554B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
GB201101959D0 (en) * 2011-02-04 2011-03-23 Univ Nottingham Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398738A (en) * 1972-12-05 1975-06-25 Pfizer Ltd Propanolamine derivatives
FI791727A (fi) * 1978-06-05 1979-12-06 Ciba Geigy Ag Foerfarande foer framstaellning av n-alkylerade aminoalkoholer
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols

Also Published As

Publication number Publication date
ES504682A0 (es) 1982-12-01
ES8305690A1 (es) 1983-05-01
ES8301462A1 (es) 1982-12-01
ES514368A0 (es) 1983-05-01
PT73511A (en) 1981-09-01
AR229188A1 (es) 1983-06-30
AU7402081A (en) 1982-02-18
ES514366A0 (es) 1983-05-01
ES514370A0 (es) 1983-06-01
IL63539A0 (en) 1981-11-30
AR231273A1 (es) 1984-10-31
AR231631A1 (es) 1985-01-31
KR840002266B1 (ko) 1984-12-14
ES514371A0 (es) 1983-05-01
AR231274A1 (es) 1984-10-31
AR231275A1 (es) 1984-10-31
GR74992B (fr) 1984-07-12
EP0045964A1 (fr) 1982-02-17
ES8305692A1 (es) 1983-05-01
ZA815554B (en) 1982-08-25
FI812465L (fi) 1982-02-14
KR830006173A (ko) 1983-09-17
ES8305691A1 (es) 1983-04-16
HU186342B (en) 1985-07-29
ES8306473A1 (es) 1983-06-01
IL63539A (en) 1984-11-30
DK358381A (da) 1982-02-14
NZ198020A (en) 1985-04-30
ES8305689A1 (es) 1983-04-16
ES514369A0 (es) 1983-05-01
ES514365A0 (es) 1983-04-16
AR231278A1 (es) 1984-10-31
ES8305693A1 (es) 1983-05-01
DD202532A5 (de) 1983-09-21
AU543647B2 (en) 1985-04-26
ES8305694A1 (es) 1983-05-01
CA1192221A (fr) 1985-08-20
ES514367A0 (es) 1983-04-16
DD202286A5 (de) 1983-09-07
NO812736L (no) 1982-02-15
PT73511B (en) 1983-07-06
JPS5759842A (en) 1982-04-10

Similar Documents

Publication Publication Date Title
DE1964516C3 (de) 1-Substituierte 3-Propionyl-anilinopyrrolidine, Verfahren zu ihrer Herstellung und Arzneimittel
EP0089637B1 (fr) Dérivés d'amino acides bicycliques, procédé pour leur préparation, agents les contenant et leur utilisation, ainsi que des amino acides bicycliques comme produits intermédiaires et procédé pour leur préparation
WO1980000152A1 (fr) Derives d'un 3-aminopropoxy-aryle, leur preparation et utilisation
EP0124476A1 (fr) Carboxamides, procédé pour leur préparation et préparations pharmaceutiques les contenant
EP0004532A1 (fr) 1-Aryloxy-3-nitratoalcoylamino-2-propanols, procédé pour leur préparation et les compositions pharmaceutiques
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE2020864B2 (de) p-Substituierte 1-Phenoxy-3-alkylaminopropan-2-ole, Herstellungsverfahren und Arzneimittel
DE3687035T2 (de) 3-aminopropyloxyphenylabkoemmlinge, herstellung und arzneitmittel die sie enthalten.
EP0065295A1 (fr) Dérivés de la tryptamine et de la thiényloxypropanolamine, procédé pour leur préparation, compositions pharmaceutiques les contenant et préparation de celles-ci
DE2531312A1 (de) Aminderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0082461B1 (fr) Phénoxyalcanolamines et phénoxyalcanol-cycloalcoylamines substituées, procédé pour leur préparation, compositions pharmaceutiques contenant ces composés et intermédiaires
CH643830A5 (de) Bis-moranolin-derivate.
DD202691A5 (de) Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
EP0389425B1 (fr) Benzothiopyranylamines
CH636858A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DE2740678A1 (de) 1-amino-2-hydroxy-3-heterocycloxypropane
DD202692A5 (de) Verfahren zur herstellung neuer derivate des 2-amino-aethanols
DE2417464A1 (de) Neue amine und verfahren zu ihrer herstellung
EP0586344B1 (fr) Dérivés d'oxazolidins et leur utilisation comme médicaments
DE3314196A1 (de) Heterocyclylaether
EP0096006A2 (fr) Dérivés de 3-(ureidocyclohexylamino)-propane-1,2-diol, procédé pour leur préparation, préparations pharmaceutiques contenant ces composés ainsi que leur utilisation thérapeutique
DE2743493A1 (de) Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel
DD141926A6 (de) Verfahren zur herstellung von neuen veraetherten hydroxybenzodiheterocyclen
EP0069838A1 (fr) Aralkylamino-éthoxy salicylamides et leur utilisation pharmaceutique
EP0086256B1 (fr) 1-(2,4-Dichlorophénoxy)-3-(3,4-diméthoxy-béta-phénethylamino)-propan-2-ol, procédé pour sa préparation et compositions pharmaceutiques le contenant